Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Journal of Experimental & Clinical Cancer Research : CR|August 29, 2020
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of RomeFabio Pelle, Sonia Cappelli, Franco Graziano, et al.
Clinical Genetics|April 27, 2011
Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA geneL Ferri, C Guido, G la Marca, et al.
Updates in Surgery|December 4, 2014
Intraoperative neuromonitoring in thyroid surgery: a point prevalence survey on utilization, management, and documentation in ItalyGianlorenzo Dionigi, Davide Lombardi, Celestino Pio Lombardi, et al.
Clinical Epigenetics|April 20, 2022
Epimutations in both the TESK2 and MMACHC promoters in the Epi-cblC inherited disorder of intracellular metabolism of vitamin B<sub>12</sub>Abderrahim Oussalah, Youssef Siblini, Sébastien Hergalant, et al.
Clinical Epigenetics|July 3, 2021
PRDX1 gene-related epi-cblC disease is a common type of inborn error of cobalamin metabolism with mono- or bi-allelic MMACHC epimutationsCatia Cavicchi, Abderrahim Oussalah, Silvia Falliano, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|February 1, 2005
[Fabry disease in Italy: first epidemiologic and collaborative study]Roberta Ricci, Mario Castorina, Mariangela Di Lillo, et al.
Human Mutation|December 30, 2014
Optimizing the molecular diagnosis of GALNS: novel methods to define and characterize Morquio-A syndrome-associated mutationsAnna Caciotti, Rodolfo Tonin, Miriam Rigoldi, et al.
Journal of Crohn'S & Colitis|October 12, 2019
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease PatientsElena Eliadou, Joana Moleiro, Davide Giuseppe Ribaldone, et al.
Cancers|August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos StudyEriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre StudyMathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Pageof 23